Tower Research Capital LLC (TRC) - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$125,390
+1513.8%
1,231
+1498.7%
0.00%
Q2 2023$7,770
+86233.3%
77
-23.0%
0.00%
Q1 2023$9
-93.3%
100
-93.3%
0.00%
-100.0%
Q4 2022$135
-99.8%
1,494
+29.8%
0.01%
+500.0%
Q3 2022$87,000
-89.9%
1,151
-88.7%
0.00%
-94.7%
Q2 2022$863,000
+276.9%
10,211
+290.2%
0.02%
+850.0%
Q1 2022$229,000
-74.4%
2,617
-74.4%
0.00%
-86.7%
Q4 2021$894,000
+5487.5%
10,215
+5007.5%
0.02%
Q3 2021$16,000
-97.3%
200
-96.9%
0.00%
-100.0%
Q2 2021$588,000
-14.2%
6,446
-19.5%
0.02%
+25.0%
Q1 2021$685,000
+3505.3%
8,010
+3905.0%
0.01%
+1100.0%
Q4 2020$19,000
-95.1%
200
-95.5%
0.00%
-75.0%
Q3 2020$385,000
+6.4%
4,427
+0.9%
0.00%
-81.8%
Q1 2020$362,000
+209.4%
4,388
+255.0%
0.02%
+120.0%
Q4 2019$117,000
-31.6%
1,236
-37.1%
0.01%
-16.7%
Q3 2019$171,000
+557.7%
1,964
+589.1%
0.01%
+500.0%
Q2 2019$26,000
-79.2%
285
-78.0%
0.00%
-75.0%
Q1 2019$125,000
+212.5%
1,297
+178.9%
0.01%
+166.7%
Q4 2018$40,000
-69.2%
465
-69.3%
0.00%
-70.0%
Q3 2018$130,000
-49.4%
1,514
-55.4%
0.01%
-28.6%
Q2 2018$257,000
+24.8%
3,395
+33.0%
0.01%
-22.2%
Q1 2018$206,000
+20500.0%
2,553
+42450.0%
0.02%
Q3 2017$1,000
-99.7%
6
-99.9%
0.00%
-100.0%
Q2 2017$338,000
+111.2%
4,054
+87.8%
0.04%
+137.5%
Q1 2017$160,000
+492.6%
2,159
+489.9%
0.02%
+433.3%
Q4 2016$27,000
-3.6%
366
+1.7%
0.00%0.0%
Q3 2016$28,000
-71.4%
360
-69.7%
0.00%
-66.7%
Q2 2016$98,000
-39.9%
1,190
-33.1%
0.01%
-43.8%
Q3 2015$163,000
-23.5%
1,778
-17.9%
0.02%
-15.8%
Q2 2015$213,000
+169.6%
2,166
+170.8%
0.02%
+90.0%
Q1 2015$79,000
-21.8%
800
-25.1%
0.01%
-9.1%
Q3 2014$101,000
+1920.0%
1,068
+1807.1%
0.01%
+1000.0%
Q2 2014$5,000
-58.3%
56
-58.2%
0.00%
-50.0%
Q1 2014$12,000
-86.8%
134
-88.1%
0.00%
-86.7%
Q4 2013$91,000
+175.8%
1,129
+163.2%
0.02%
+275.0%
Q3 2013$33,000
+3200.0%
429
+2423.5%
0.00%
Q2 2013$1,000170.00%
Other shareholders
NOVARTIS A G shareholders Q2 2021
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders